Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2010

Open Access 01-12-2010 | Research Article

Which factors predict the time spent answering queries to a drug information centre?

Authors: Linda A. Reppe, Olav Spigset, Jan Schjøtt

Published in: International Journal of Clinical Pharmacy | Issue 6/2010

Login to get access

Abstract

Objective To develop a model based upon factors able to predict the time spent answering drug-related queries to Norwegian drug information centres (DICs). Setting and method Drug-related queries received at 5 DICs in Norway from March to May 2007 were randomly assigned to 20 employees until each of them had answered a minimum of five queries. The employees reported the number of drugs involved, the type of literature search performed, and whether the queries were considered judgmental or not, using a specifically developed scoring system. Main outcome measures The scores of these three factors were added together to define a workload score for each query. Workload and its individual factors were subsequently related to the measured time spent answering the queries by simple or multiple linear regression analyses. Results Ninety-six query/answer pairs were analyzed. Workload significantly predicted the time spent answering the queries (adjusted R2 = 0.22, P < 0.001). Literature search was the individual factor best predicting the time spent answering the queries (adjusted R2 = 0.17, P < 0.001), and this variable also contributed the most in the multiple regression analyses. Conclusion The most important workload factor predicting the time spent handling the queries in this study was the type of literature search that had to be performed. The categorisation of queries as judgmental or not, also affected the time spent answering the queries. The number of drugs involved did not significantly influence the time spent answering drug information queries.
Literature
1.
go back to reference Grace M, Wertheimer AI. Judgmental questions processed by a drug information center. Am J Hosp Pharm. 1975;32(9):903–4.PubMed Grace M, Wertheimer AI. Judgmental questions processed by a drug information center. Am J Hosp Pharm. 1975;32(9):903–4.PubMed
2.
go back to reference Cardoni AA, Thompson TJ. Impact of drug information services on patient care. Am J Hosp Pharm. 1978;35(10):1233–7.PubMed Cardoni AA, Thompson TJ. Impact of drug information services on patient care. Am J Hosp Pharm. 1978;35(10):1233–7.PubMed
3.
go back to reference Meinhold JM, Nelson AA Jr, Hutchinson RA. Changes in drug information inquiries following implementation of clinical pharmaceutical services. Am J Hosp Pharm. 1979;36(11):1520–3.PubMed Meinhold JM, Nelson AA Jr, Hutchinson RA. Changes in drug information inquiries following implementation of clinical pharmaceutical services. Am J Hosp Pharm. 1979;36(11):1520–3.PubMed
4.
go back to reference Merritt GJ, Garnett WR, Eckel FM. Analysis of a hospital-based information center. Am J Hosp Pharm. 1977;34(1):42–6.PubMed Merritt GJ, Garnett WR, Eckel FM. Analysis of a hospital-based information center. Am J Hosp Pharm. 1977;34(1):42–6.PubMed
5.
go back to reference Romá E, Planells C, Carrera A, Cercõs AC, Sánchez S, Gallego C. Quality management in drug information. Eur Hosp Pharm. 1995;1(2):61–6. Romá E, Planells C, Carrera A, Cercõs AC, Sánchez S, Gallego C. Quality management in drug information. Eur Hosp Pharm. 1995;1(2):61–6.
6.
go back to reference Davies DM, Ashton CH, Rao JG, Rawlins MD, Routledge PA, Savage RL, et al. Comprehensive clinical drug information service: first year’s experience. Br Med J. 1977;1(6053):89–90.CrossRefPubMed Davies DM, Ashton CH, Rao JG, Rawlins MD, Routledge PA, Savage RL, et al. Comprehensive clinical drug information service: first year’s experience. Br Med J. 1977;1(6053):89–90.CrossRefPubMed
7.
go back to reference Morrow NC, D’Arcy PF, Pielou LW. Drug information inquiries—who asks what and where are the answers? J Clin Hosp Pharm. 1984;9(4):321–31.PubMed Morrow NC, D’Arcy PF, Pielou LW. Drug information inquiries—who asks what and where are the answers? J Clin Hosp Pharm. 1984;9(4):321–31.PubMed
8.
go back to reference Smith CJ, Sylvia LM. External quality assurance committee for drug information services. Am J Hosp Pharm. 1990;47(4):787–91.PubMed Smith CJ, Sylvia LM. External quality assurance committee for drug information services. Am J Hosp Pharm. 1990;47(4):787–91.PubMed
9.
go back to reference Joy ME, Arana CJ, Gallo GR. Use of information sources at a university hospital drug information service. Am J Hosp Pharm. 1986;43(5):1226–9.PubMed Joy ME, Arana CJ, Gallo GR. Use of information sources at a university hospital drug information service. Am J Hosp Pharm. 1986;43(5):1226–9.PubMed
11.
go back to reference Schjøtt J, Pomp E, Gedde-Dahl A. Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians? Eur J Clin Pharmacol. 2002;57(12):897–902.CrossRefPubMed Schjøtt J, Pomp E, Gedde-Dahl A. Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians? Eur J Clin Pharmacol. 2002;57(12):897–902.CrossRefPubMed
12.
go back to reference Baxter K. Stockley’s Drug Interactions 8th ed. Pharmaceutical Press, London, 2008. ISBN 978-0-85369-754-1. Baxter K. Stockley’s Drug Interactions 8th ed. Pharmaceutical Press, London, 2008. ISBN 978-0-85369-754-1.
14.
go back to reference Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. A reference guide to fetal and neonatal risk. 5th ed. Lippincott Williams and Wilkins, 2005. ISBN 978-0-7817-7876-3. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. A reference guide to fetal and neonatal risk. 5th ed. Lippincott Williams and Wilkins, 2005. ISBN 978-0-7817-7876-3.
16.
go back to reference Llerena A, Öhman B, Alván G. References used in a drug information centre. Eur J Clin Pharmacol. 1995;49(1–2):87–9.PubMed Llerena A, Öhman B, Alván G. References used in a drug information centre. Eur J Clin Pharmacol. 1995;49(1–2):87–9.PubMed
17.
go back to reference Widnes SKF, Schjøtt J. Advice on drug safety in pregnancy. Are there differences between commonly used sources of information? Drug Saf. 2008;31(9):799–806.CrossRef Widnes SKF, Schjøtt J. Advice on drug safety in pregnancy. Are there differences between commonly used sources of information? Drug Saf. 2008;31(9):799–806.CrossRef
Metadata
Title
Which factors predict the time spent answering queries to a drug information centre?
Authors
Linda A. Reppe
Olav Spigset
Jan Schjøtt
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2010
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-010-9440-7

Other articles of this Issue 6/2010

International Journal of Clinical Pharmacy 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.